Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 ARGX-119
(a fully humanized immunoglobulin gamma 1 that specifically targets and activates MuSK)		[1] ARGX-119---[2] 2, 12 💬
2 Human immunoglobulin G
(Immunoglobulin G)		[6] Human immunoglobulin G; Human normal immunoglobulin; Immune globulin; Immunoglobulin; Immunoglobulin G; Intravenous immunoglobulin[1] Globulin, immune 💬 --[9] 11, 13, 14, 43, 45, 50, 51, 63, 65 💬
3 OMS906
(Humanized immunoglobulin G4 monoclonal antibody directed against mannan-binding lectin-associated serine protease-3)		[0] ---[1] 62 💬
4 Talquetamab
(IMMUNOGLOBULIN G4)		[1] Talquetamab[1] Talquetamab 💬 [1] CD3E 💬 [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 28 💬
5 Telitacicept
(FUSION PROTEIN WITH HUMAN IMMUNOGLOBULIN G1)		[1] Telitacicept---[11] 11, 13, 46, 48, 49, 51, 53, 63, 66, 222, 300 💬